6:28 PM
 | 
Oct 18, 2012
 |  BC Extra  |  Financial News

Cleveland BioLabs planning follow-on

Cleveland BioLabs Inc. (NASDAQ:CBLI) said late Thursday it is planning a follow-on underwritten by Oppenheimer; Cantor Fitzgerald; and Ladenburg Thalmann. Cleveland BioLabs is developing CBLB502 for...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >